相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cardiac ultrastructure inspired matrix induces advanced metabolic and functional maturation of differentiated human cardiomyocytes
Junaid Afzal et al.
CELL REPORTS (2022)
Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy
Ampadu O. Jackson et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure
Alexey A. Konev et al.
ESC HEART FAILURE (2020)
A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes
Razan Elfadil Ahmed et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients
Rikke Hjortebjerg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
Per Winkel et al.
BMJ OPEN (2020)
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
Junjun Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cardioprotective effect of IGF-1 against myocardial ischemia/reperfusion injury through activation of PI3K/Akt pathway in rats in vivo
Yaojun Liao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells
Andre Heinen et al.
MOLECULAR THERAPY (2019)
Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes
Cheryl A. Conover et al.
PHYSIOLOGICAL REPORTS (2019)
Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients
Alexey A. Konev et al.
CLINICAL BIOCHEMISTRY (2018)
IGFBP-4 and PAPP-A in normal physiology and disease
Rikke Hjortebjerg
GROWTH HORMONE & IGF RESEARCH (2018)
Role of IGF-binding proteins in regulating IGF responses to changes in metabolism
David R. Clemmons
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Chengyi Tu et al.
CIRCULATION RESEARCH (2018)
An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion
Maria V. Shutova et al.
CELL CYCLE (2016)
Creation of a library of induced pluripotent stem cells from Parkinsonian patients
Staffan Holmqvist et al.
NPJ PARKINSONS DISEASE (2016)
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Insights Into Molecular, Cellular, and Functional Phenotypes
Ioannis Karakikes et al.
CIRCULATION RESEARCH (2015)
Characterization of endogenously circulating IGFBP-4 fragments-Novel biomarkers for cardiac risk assessment
Alexey A. Konev et al.
CLINICAL BIOCHEMISTRY (2015)
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells
Jong J. Kim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
The role of PAPP-A in the IGF system: location, location, location
Claus Oxvig
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2015)
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype
Christine Y. Ivashchenko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling
Olalla Iglesias-Garcia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Correction: Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells
Guang Qin Zhang et al.
PLoS One (2013)
N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia
A. B. Postnikov et al.
CLINICAL BIOCHEMISTRY (2012)
Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells
Cheryl A. Conover et al.
GROWTH HORMONE & IGF RESEARCH (2008)
Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts
ZT Resch et al.
ENDOCRINOLOGY (2006)
Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol
CA Conover et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy
QP Qin et al.
CLINICAL CHEMISTRY (2005)
Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein - Disulfide structure and carbohydrate attachment sites
MT Overgaard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity - Reversible adhesion is mediated by two neighboring short consensus repeats
LS Laursen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis
LS Laursen et al.
BIOCHEMICAL JOURNAL (2002)
Pregnancy-associated plasma protein a as a marker of acute coronary syndromes
A Bayes-Genis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A
LS Laursen et al.
FEBS LETTERS (2001)
Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty
A Bayes-Genis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)